IPO registrations (S-1, F-1) · Registrants
vTv Therapeutics Inc.
- SEC CIK
- 1641489 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2015-06-15, last 2020-11-24; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2015-07-31; declared effective 2015-07-29
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 3980 PREMIER DR, SUITE 310, High Point, NC 27265
- EIN
- 47-3916571
- Ticker
- VTVT (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- vTv Therapeutics Inc. on the corporate pages
Offering terms
- Proposed price range
- $15.00–$17.00 per share (S-1/A filed 2015-07-24)
- Final price
- $15.00 per share, within the range (424B4 filed 2015-07-31, an initial public offering)
- Shares sold
- 7,812,500
- Gross proceeds
- $117,187,500 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol VTVT
- Lead underwriters
- Piper Sandler
- Syndicate
- Stifel; Janney Montgomery Scott
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: vTv Therapeutics Inc. EXACT (CIK (EXACT))
- SEC filer: vTv Therapeutics Inc. EXACT (CIK (EXACT))
- Person page: Barry K Brown Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: Paul G Savas Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 15
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-06-15 | S-1 | S-1 (registration) | vTv Therapeutics Inc. | 0001567619-15-000828 ↗ |
| 2015-06-19 | S-1/A | S-1/A (amendment) | vTv Therapeutics Inc. | 0001567619-15-000855 ↗ |
| 2015-07-02 | S-1/A | S-1/A (amendment) | vTv Therapeutics Inc. | 0001567619-15-000912 ↗ |
| 2015-07-13 | S-1/A | S-1/A (amendment) | vTv Therapeutics Inc. | 0001567619-15-000943 ↗ |
| 2015-07-20 | S-1/A | S-1/A (amendment) | vTv Therapeutics Inc. | 0001567619-15-000955 ↗ |
| 2015-07-23 | S-1/A | S-1/A (amendment) | vTv Therapeutics Inc. | 0001567619-15-000982 ↗ |
| 2015-07-24 | S-1/A | S-1/A (amendment) | vTv Therapeutics Inc. | 0001567619-15-000986 ↗ |
| 2015-07-29 | EFFECT | EFFECT (declared effective) | vTv Therapeutics Inc. | 9999999995-15-002099 ↗ |
| 2015-07-31 | 424B4 | 424B4 (final prospectus) | vTv Therapeutics Inc. | 0001567619-15-001033 ↗ |
| 2018-03-19 | EFFECT | EFFECT (declared effective) | vTv Therapeutics Inc. | 9999999995-18-000631 ↗ |
| 2019-07-15 | EFFECT | EFFECT (declared effective) | vTv Therapeutics Inc. | 9999999995-19-001607 ↗ |
| 2020-11-24 | S-1 | S-1 (registration) | vTv Therapeutics Inc. | 0001564590-20-055088 ↗ |
| 2020-12-08 | EFFECT | EFFECT (declared effective) | vTv Therapeutics Inc. | 9999999995-20-003446 ↗ |
| 2021-04-20 | EFFECT | EFFECT (declared effective) | vTv Therapeutics Inc. | 9999999995-21-001506 ↗ |
| 2021-06-11 | EFFECT | EFFECT (declared effective) | vTv Therapeutics Inc. | 9999999995-21-002316 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-07-24 | S-1/A | registration statement | $15.00–$17.00 | 7,812,500 | - | Nasdaq VTVT | 3 | primary document; range, shares headline, cover names 3 | document ↗ | |
| 2015-07-31 | 424B4 | final prospectus | $15.00 | 7,812,500 | $117,187,500 | Nasdaq VTVT | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Cohen Steven Michael | Director | 2 | 2015 | ||
| Holcombe Stephen L. | Officer | President & CEO | 5 | 2015–2020 | |
| HOWARD RUDY | Officer | CFO & Secretary; Chief Financial Officer | 5 | 2015–2020 | |
| KINDLER JEFFREY B | Director; Director,Officer | Executive Chairman | 8 | 2015–2020 | |
| MEISTER PAUL M | Director | 1 | 2015 | ||
| Parker Craig C | Director | 5 | 2015–2018 | ||
| PERELMAN RONALD O | TenPercentOwner | 64 | 2015–2021 | ||
| SAVAS PAUL G | Director | 12 | 2015–2018 | person page Fuzzy | |
| Spiegel Noel Joseph | Director | 10 | 2015–2021 | ||
| ALTSTIEL LARRY DOUGLAS | Officer | Chief Medical Officer | 3 | 2015–2017 | |
| FRY JOHN A | Director | 10 | 2016–2023 | ||
| Weiner Howard L. | Director | 7 | 2017–2023 | ||
| KOZLOV HERSH | Director | 8 | 2019–2023 | ||
| Taibi Edward P. | Director | 1 | 2020 | ||
| Nelson Rich S. | Director; Director,Officer | Acting Chief Executive Officer | 3 | 2020–2022 | |
| Abrams Robin Elizabeth | Director | 1 | 2020 | ||
| Prasad Deepa | Director,Officer | President and CEO | 2 | 2021 | |
| Al-Marzooqi Fahed | Director | 7 | 2022–2026 | ||
| G42 Investments AI Holdings RSC Ltd. | Director,TenPercentOwner | 1 | 2022 | ||
| Harjivan Chandresh | Director | 3 | 2022–2023 | ||
| Al-Nahyan Tahnoon Bin Zayed S. | TenPercentOwner | 1 | 2022 | ||
| SEKHRI PAUL J | Director,Officer | Pres, CEO and Exec Chairperson; President and CEO | 5 | 2022–2026 | |
| Harris Keith R. | Director | 3 | 2022–2023 | ||
| Isaacsohn Jonathan | Director | 3 | 2022–2023 | ||
| Tuch Steven L. | Officer | Chief Financial Officer | 3 | 2022–2024 | |
| Brown Barry K. | Officer | Chief Accounting Officer | 2 | 2023–2025 | person page Fuzzy |
| AKKARAJU SRINIVAS | Director; Director,TenPercentOwner | 9 | 2024–2026 | ||
| Samsara BioCapital GP, LLC | TenPercentOwner | 2 | 2024 | ||
| Samsara BioCapital, L.P. | TenPercentOwner | 2 | 2024 | ||
| 667, L.P. | Director | 6 | 2024–2026 | ||
| Baker Bros. Advisors (GP) LLC | Director | 6 | 2024–2026 | ||
| BAKER BROS. ADVISORS LP | Director | 6 | 2024–2026 | ||
| Baker Brothers Life Sciences LP | Director | 6 | 2024–2026 | ||
| BAKER FELIX | Director | 6 | 2024–2026 | ||
| BAKER JULIAN | Director | 6 | 2024–2026 | ||
| Cheong Raymond | Director | 1 | 2024 | ||
| Phillips Anne M. | Director | 5 | 2024–2026 | ||
| SPIEGELMAN DANIEL K | Director | 4 | 2024–2026 | ||
| Tung Michael Stephen | Officer | EVP & CFO | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-03-07 | vTv Therapeutics Inc. | Pharmaceuticals | $50,961,457 | $50,961,457 | 4 | 1 |
| 2020-01-17 | vTv Therapeutics Inc. | Pharmaceuticals | $10,000,000 | $2,000,000 | 0 | 1 |
| 2019-10-15 | vTv Therapeutics Inc. | Pharmaceuticals | $10,000,000 | $2,000,000 | 0 | 1 |
| 2019-07-09 | vTv Therapeutics Inc. | Pharmaceuticals | $9,000,000 | $4,000,000 | 0 | 1 |
| 2019-01-04 | vTv Therapeutics Inc. | Pharmaceuticals | $10,000,000 | $1,500,000 | 0 | 1 |
| 2018-08-10 | vTv Therapeutics Inc. | Pharmaceuticals | $10,000,000 | $0 | 0 | 1 |
| 2017-12-19 | vTv Therapeutics Inc. | Pharmaceuticals | $10,000,000 | $10,000,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | VTV THERAPEUTICS LLC | NC | Form 5500 (employee benefit plans) | name and state |
| Plan sponsor | VTV THERAPEUTICS, LLC | NC | Form 5500 (employee benefit plans) | name and state |
| Form D issuer | vTv Therapeutics Inc. | NC | Form D private offerings | CIK (EXACT) |
| Patent assignee | VTV THERAPEUTICS LLC | NC | Patents (USPTO) | name and state |
| SEC filer | vTv Therapeutics Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | vTv Therapeutics LLC | NC | Trademarks (USPTO) | name and state |
| Person page | Barry K Brown | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | Paul G Savas | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NC first:
- SALIX PHARMACEUTICALS LTD NC
- TRIANGLE PHARMACEUTICALS INC NC
- INSPIRE PHARMACEUTICALS INC NC
- POZEN INC /NC NC
- ARGOS THERAPEUTICS INC NC
- CHIMERIX INC NC
- ENDEAVOR PHARMACEUTICALS INC NC
- CORNERSTONE THERAPEUTICS INC NC
- Talecris Biotherapeutics Holdings Corp. NC
- Biolex Therapeutics, Inc. NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health